Active	Status	Sponsor type	Region	Phase	Filter
3 Active 30 Inactive 33 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Wolzt, Michael
NCT05217654: Trial to Investigate the Effect of Dapagliflozin on Ischemia Reperfusion Induced Endothelial Dysfunction	Recruiting	1	32	Europe	Dapagliflozin 10mg, Forxiga 10mg Tabletten, Placebo, Placebo tablets	Medical University of Vienna	Reperfusion Injury, Vascular Complications	02/23	08/23
NCT04138186: G-PUR® for Symptomatic Treatment in Irritable Bowel Syndrome With Diarrhea	Recruiting	N/A	30	Europe	2.0g G-PUR®, oral administration, Placebo, oral administration	Glock Health, Science and Research GmbH	Irritable Bowel Syndrome With Diarrhea (IBS-D)	02/21	02/21
NCT04584372: Dietary Nitrate, Vascular Function and Inflammation	Completed	N/A	20	Europe	High-nitrate intervention, HI-NI, Low-nitrate intervention, LO-NI	University of Vienna, Medical University of Vienna, Queensland University of Technology, Flinders University, Edith Cowan University	Hypertension, Inflammation	03/23	03/23